Delivery Order SPE2DB20D3103-SPE2DB25FQ3M7
- Not listed
- The Defense Logistics Agency awarded a $52,402.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 1 mg/dose in 3 mL vials, with a completion date of September 15, 2025. This is a competitively awarded, non-set-aside contract with performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending...
- The Defense Logistics Agency awarded a $29,120.01 delivery order to AmerisourceBergen Drug Corp for Ozempic (semaglutide) 1 mg/dose in 3 mL vials. The contract, awarded on August 18, 2025, with completion targeted for August 19, 2025, utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award based on capability. Performance will be executed from AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $4,893.47 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 ml vials. This non-competitive, firm fixed-price delivery order was awarded on September 15, 2025, with an ultimate completion date of September 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a routine pharmaceutical procurement within the...
- The Defense Logistics Agency awarded a $32,686.40 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 1 mg/dose in 3 mL vials on September 19, 2025, with completion scheduled for September 22, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $3,455.97 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3mL vials. This is a firm fixed price, non-competitive set-aside contract with an ultimate completion date of June 2, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution operations. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,879.98 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3ml vials. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of September 26, 2025. The award was issued on September 25, 2025, and the pharmaceutical will be delivered to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $15,380.88 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This contract, awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $9,392.34 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25–0.5 mg/dose pens in 3 mL formulations. This competitively awarded, firm fixed-price contract was issued on July 23, 2025, with an ultimate completion date of July 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation, reflecting the open...
- The Defense Logistics Agency awarded a delivery order valued at $2,838.00 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. The contract was competitively awarded on August 27, 2025, with a firm fixed price structure and an ultimate completion date of August 28, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order carries no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order valued at $17,745.69 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials. The contract, issued on September 4, 2025, with a completion date of September 5, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work from its corporate office...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ3M7Delivery Order
The Defense Logistics Agency awarded a $22,373.10 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 2 mg/dose in 3 mL vials. This competitive award, issued on September 17, 2025, with a completion date of September 18, 2025, reflects a firm fixed-price delivery order under a larger contract vehicle. The order is being fulfilled from the vendor's Corporate Office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters. As a non-set-aside award, this contract was competitively procured in accordance with standard federal acquisition regulations. This delivery order falls under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates its established capability as a major pharmaceutical distributor supporting critical medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible and competitively awarded contract mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.4k | 9/17/25 |